AI Stock Analysis - Kenvue (KVUE)
Analysis generated November 3, 2025.
Kenvue is a player in the industry providing health and personal care products. The company has built a foundation in a competitive market with a broad range of offerings and a growing customer base. Despite its reputable brand and market share, Kenvue currently faces several challenges as indicated by recent fundamental, technical, and alternative data analyses, which we will explore in depth below.
Stock Alerts - Kenvue (KVUE)
 |
Kenvue | May 13 Insider Alert: Orlando Matthew is selling shares |
|
Kenvue | April 22 Employee Rating is up by 2.9% over the last month. |
|
Kenvue | April 8 Job postings are down by 20.7% in the last couple of days. |
|
Kenvue | April 6 Kevin Hern (member of U.S. congress) is selling shares |
Download our app on iOS or Android to get future alerts delivered in real-time.
Alternative Data for Kenvue
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 374 | Sign up | Sign up | Sign up |
| Sentiment | 56 | Sign up | Sign up | Sign up |
| Webpage traffic | 279,000 | Sign up | Sign up | Sign up |
| Employee Rating | 70 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 3,453 | Sign up | Sign up | Sign up |
| Facebook Followers | 5,551 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 11 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,301 | Sign up | Sign up | Sign up |
| X Followers | 1,646 | Sign up | Sign up | Sign up |
| X Mentions | 46 | Sign up | Sign up | Sign up |
| News Mentions | 3 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 39 | Sign up | Sign up | Sign up |
| Linkedin Employees | 19,655 | Sign up | Sign up | Sign up |
About Kenvue
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health.
| Price | $17.19 |
| Target Price | Sign up |
| Volume | 20,211,856 |
| Market Cap | $33.5B |
| Year Range | $13.78 - $20.06 |
| Dividend Yield | 4.82% |
| PE Ratio | 20.8 |
| Analyst Rating | 44% buy |
| Industry | Consumer Packaged Goods |
In the news
Dermal Mycosis Market Research Report 2025-2026 & 2035, Competitive Analysis of Bayer, Kenvue, Karo Healthcare, Novartis, Glenmark Pharmaceuticals, Sun Pharma, Teva, and SandozApril 28 - GlobeNewswire |
|
 |
Drugmaker FDC goes to court on similar-sounding electrolyte drink eRZL from J&J/KenvueApril 8 - BusinessLine |
Kenvue Inc. (KVUE) PT Lifted to $19 at Barclays After Q4 UpdateMarch 15 - Yahoo Entertainment |
|
UBS Raises Kenvue Inc. (KVUE) Price Target to $19 After Strong Q4 ResultsMarch 10 - Yahoo Entertainment |
|
Here’s Why SCCM Enhanced Equity Portfolio Exited Its Position in Kenvue (KVUE)March 2 - Yahoo Entertainment |
|
 |
Kimberly-Clark Details “Powering Care” Plan, Kenvue Integration Ahead of 2026 CloseFebruary 23 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '26 | 3.91B | 1.61B | 2.3B | 474M | 767M | 0.320 |
| Q4 '25 | 3.78B | 1.64B | 2.14B | 330M | 663M | 0.170 |
| Q3 '25 | 3.76B | 1.54B | 2.23B | 398M | 760M | 0.280 |
| Q2 '25 | 3.84B | 1.58B | 2.26B | 420M | 837M | 0.220 |
| Q1 '25 | 3.74B | 1.57B | 2.17B | 322M | 701M | 0.240 |
Insider Transactions View All
| Smith Jeffrey C filed to buy 27,307,632 shares at $17.4. December 15 '25 |
| Smith Jeffrey C filed to buy 24,107,632 shares at $17.4. December 15 '25 |
| Lawson Carlton filed to sell 56,316 shares at $23. March 14 '25 |
| ALLISON RICHARD E JR filed to buy 25,598 shares at $23. August 31 '23 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Unilever PLCUL |
$57.5 0.7% | 37 |
 |
Procter & GamblePG |
$142.24 1.2% | 46 |
 |
Tyson FoodsTSN |
$66.89 0.8% | 55 |
 |
The Hershey CompanyHSY |
$195.67 2% | 53 |
 |
Beyond MeatBYND |
$0.78 1.3% | 21 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Kevin Hern |
Apr 6, 26 | Sell | $15K - $50K |
| Gilbert Cisneros |
Mar 10, 26 | Buy | $1K - $15K |
| Gilbert Cisneros |
Feb 16, 26 | Sell | $1K - $15K |
Read more about Kenvue (KVUE) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Kenvue
The Market Cap of Kenvue is $33.5B.
As of today, Kenvue's PE (Price to Earnings) ratio is 20.8.
Currently, the price of one share of Kenvue stock is $17.19.
The KVUE stock price chart above provides a comprehensive visual representation of Kenvue's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Kenvue shares. Our platform offers an up-to-date KVUE stock price chart, along with technical data analysis and alternative data insights.
Yes, Kenvue (KVUE) offers dividends to its shareholders, with a dividend yield of 4.82%. This dividend yield represents Kenvue's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Kenvue in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
Some of the similar stocks of Kenvue are Unilever PLC, Procter & Gamble, Tyson Foods, The Hershey Company, and Beyond Meat.
